Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Cancer
Interventions: GENETIC: KRAS-variant and microRNA binding site mutation testing
Sponsor: MiraKind